AC Immune has received FDA Fast Track designation and IND [...]

Oncoinvent has published Phase 1 dosimetry data for Radspherin in [...]

Alamar Biosciences is expanding a partnership with the Alzheimer’s Disease [...]

OSF HealthCare is expanding its use of RapidAI’s clinical AI [...]

Zilucoplan has been accepted for restricted use in NHS Scotland [...]

AstronauTx has exercised its option to acquire worldwide rights to [...]

BioVie has reported topline results from a Phase 2 trial [...]

AC Immune has outlined a series of clinical milestones expected [...]

ABLi Therapeutics has reported coordinated changes across 11 biomarkers linked [...]

Vaximm AG has completed analysis of two clinical studies evaluating [...]